Matthias Nees

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Ketogenic Diet as an Adjuvant in Epithelial Cancers: Mechanisms, Model Systems, and Translational Opportunities.

Ketogenic Diet as an Adjuvant in Epithelial Cancers: Mechanisms, Model Systems, and Translational Opportunities.

Journal: Cancers

Published: July 03, 2026

Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma (HNSCC): The Role of Histone Methyltransferase and Demethylase Inhibitors.

Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma (HNSCC): The Role of Histone Methyltransferase and Demethylase Inhibitors.

Journal: Cancers

Published: May 04, 2026

Tumor-on-chip platforms for transport phenotyping: decoding CAF-driven barriers to drug delivery.

Tumor-on-chip platforms for transport phenotyping: decoding CAF-driven barriers to drug delivery.

Journal: Lab on a chip

Published: April 13, 2026

A Patient-Derived Scaffold-Based 3D Culture Platform for Head and Neck Cancer: Preserving Tumor Heterogeneity for Personalized Drug Testing.

A Patient-Derived Scaffold-Based 3D Culture Platform for Head and Neck Cancer: Preserving Tumor Heterogeneity for Personalized Drug Testing.

Journal: Cells

Published: August 12, 2025

Genipin-Crosslinked, Silane-Anchored 3D Tumor-Stroma Microtissues for High-Content On-Chip Drug Testing.

Genipin-Crosslinked, Silane-Anchored 3D Tumor-Stroma Microtissues for High-Content On-Chip Drug Testing.

Journal: Advanced healthcare materials

Published: July 18, 2025

Targeting fatty acid-binding protein 4: A therapeutic intersection of obesity and cancer via lipid metabolism.

Targeting fatty acid-binding protein 4: A therapeutic intersection of obesity and cancer via lipid metabolism.

Journal: Progress in lipid research

Published: June 28, 2025

Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.

Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 12, 2025

Loss of Sirtuin 7 impairs cell motility and proliferation and enhances S-phase cell arrest after 5-fluorouracil treatment in head and neck cancer.

Loss of Sirtuin 7 impairs cell motility and proliferation and enhances S-phase cell arrest after 5-fluorouracil treatment in head and neck cancer.

Journal: Scientific reports

Published: July 11, 2024

Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models.

Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models.

Journal: Cancer medicine

Published: June 06, 2024

The Notch inhibitor, FLI-06, increases the chemosensitivity of head and neck Squamous cell carcinoma cells to taxanes-based treatment.

The Notch inhibitor, FLI-06, increases the chemosensitivity of head and neck Squamous cell carcinoma cells to taxanes-based treatment.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 24, 2024

Surface Modification of Mesoporous Silica Nanoparticles as a Means to Introduce Inherent Cancer-Targeting Ability in a 3D Tumor Microenvironment.

Surface Modification of Mesoporous Silica Nanoparticles as a Means to Introduce Inherent Cancer-Targeting Ability in a 3D Tumor Microenvironment.

Journal: Small science

Published: February 28, 2024

Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models.

Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models.

Journal: Translational oncology

Published: December 13, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026